Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
: COMPANY NAME CHANGE The Company has announced that it is convening a General Meeting of the Company on 11 July 2014 to seek approval for a Change of Name of the Company to YOLO Leisure and Technology plc. Terms: All securities under Pentagon Protection plc will change Issuer Name to YOLO Leisure and Technology plc subject to Shareholders approval. Further information may follow in due course.
What a run this has had for 2 weeks..I met with a friend who is a financial advisor who thought uranium is out the game. Fair opinion as per unfashionable with some European countries, namely Germany. But i suspect the catalyst of Japan's reactors and a bad commodities market weighed too much here, hopefully now is being corrected...
it doesn't look like the company has issued any new shares to the market. but shares issued to appear up in the statement of changes in equity. so i presume the board has taken up options in the company. if anybody can add to this please do because I'm sure it was a concern early this month. IMO GLA and please correct me if I'm wrong.
http://www.investegate.co.uk/pentagon-protection--ppr-/rns/final-results/201402210700075922A/
Strategic Focus We currently have a sales pipeline of £19.4m, almost three-quarters of which is in Africa, demonstrating the commitment we have made to the continent. Of course this comes with more risk, as these projects take longer to close and care needs to be taken to ensure revenues are collected. We have implemented controls and procedures to address these issues.
this is where i had imagined the share price to be but i did not expect it to get here so fast. Saying that Grayling is right the share has under preformed for a long time. Though i am new to the concept of reporting a good forecast fr 2017 and rising in 2014. Its 3 years down the line a lot can change. This company was undervalued and if this falls by any amount then its in undervalued territory. Pharmaceuticals sector in general has not preformed like it has done so in the past. Though AZN was even worse off the sector as a comparison. The growth of this company has been outstanding untill 2009-present. The recession took it out this company also i believe Obamacare along with patents/R+D affected the years previous. Though now AZN are looking to restore themselves which i believe they are capable of. Old boring but safe. GLA
Had you re-invested dividends ? I'm very interested in such a company like this. There growth since 1990's has been outstanding beating GSK hands down until 2009. Where also the FTSE100 has beat this share, as well as the pharma's in general. I like that this company is a specialist company in drugs. (Which i believe in the long run will only increase over the years)This is a very good company being undervalued a lot that when the FTSE100 falls, it will be undervalued more! I would be interested to hear more comments on the company from you Bobsbargains...